Intrinsiqq
Pacs Group Inc. logo

Pacs Group Inc. (PACS) Insider Trading

Last 12 months

Insiders bought $500k and sold $94.5M on the open market.

93% of the selling was scheduled in advance under 10b5-1 plans. Chief Legal Officer & Sec. John Todd Mitchell sold $4.77M on Nov 24, 2025, 17% of their stake, outside a plan.

Net open-market
−$94M
1 buy · 26 sales
Under a 10b5-1 plan
93%
of the value sold
Insiders who bought / sold
1 / 6
executives and directors
Last open-market buy
Nov 2025
Nov 24, 2025

Get an email when PACS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 19 – 2110b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 45,707 at avg $47.64
    $2.18M
    <0.1% of stake
  • Oct 14 – 1610b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 118,729 at avg $47.29
    $5.61M
    0.2% of stake
  • Oct 1410b5-1 plan
    Joshua Jergensen
    President & COO · sold 40,000 at $44.50
    $1.78M
    1.6% of stake
  • Oct 6 – 710b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 36,692 at avg $43.08
    $1.58M
    <0.1% of stake
  • Oct 1 – 510b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 83,308 at avg $42.00
    $3.5M
    0.2% of stake
  • Sep 1610b5-1 plan
    Joshua Jergensen
    President & COO · sold 40,000 at avg $43.13
    $1.73M
    1.6% of stake
  • Sep 14 – 1510b5-1 plan
    Mark Hancock
    Director · sold 300,000 at avg $43.48
    $13M
    0.6% of stake
  • Sep 10 – 1410b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 19,617 at avg $45.20
    $887k
    <0.1% of stake
  • Sep 4 – 910b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 51,887 at avg $43.12
    $2.24M
    <0.1% of stake
  • Sep 1 – 310b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 68,113 at avg $42.63
    $2.9M
    0.1% of stake
  • Aug 20 – 2110b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 150,550 at avg $43.92
    $6.61M
    0.3% of stake
  • Aug 17 – 1910b5-1 plan
    Jason Hulse Murray
    Co-Founder, CEO & Chairman · sold 236,116 at avg $44.20
    $10.4M
    0.4% of stake
  • Aug 14No plan
    Patrick Hugh Conway
    Director · sold 3,497 at $44.41
    $155k
    28% of stake
  • Aug 1210b5-1 plan
    Joshua Jergensen
    President & COO · sold 40,000 at avg $45.59
    $1.82M
    1.6% of stake
  • Jul 14 – 1510b5-1 plan
    Mark Hancock
    Director · sold 13,628 at avg $45.04
    $614k
    <0.1% of stake
  • Jul 1510b5-1 plan
    Joshua Jergensen
    President & COO · sold 40,000 at avg $45.02
    $1.8M
    1.5% of stake
  • Jul 8 – 910b5-1 plan
    Mark Hancock
    Director · sold 25,304 at avg $45.07
    $1.14M
    <0.1% of stake
  • Jul 1 – 610b5-1 plan
    Mark Hancock
    Director · sold 161,068 at avg $45.29
    $7.3M
    0.3% of stake
  • Jul 1 – 610b5-1 plan
    Michelle Renee Lewis
    Chief Accounting Officer · sold 15,000 at avg $45.03
    $675k
    4.1% of stake
  • Jun 25 – 2610b5-1 plan
    Mark Hancock
    Co Fndr; Exec V Chair · sold 200,000 at avg $40.38
    $8.08M
    0.4% of stake
  • Jun 2510b5-1 plan
    Michelle Renee Lewis
    Chief Accounting Officer · sold 15,000 at $40.01
    $600k
    3.9% of stake
  • Jun 1710b5-1 plan
    Mark Hancock
    Co Fndr; Exec V Chair · sold 63,680 at avg $35.30
    $2.25M
    0.1% of stake
  • Jun 15 – 1610b5-1 plan
    Mark Hancock
    Co Fndr; Exec V Chair · sold 236,320 at avg $36.18
    $8.55M
    0.4% of stake
  • May 15 – 1810b5-1 plan
    John Todd Mitchell
    Chief Legal Officer & Sec. · sold 80,152 at avg $37.72
    $3.02M
    9.1% of stake
  • Mar 13No plan
    Joshua Jergensen
    President & COO · sold 36,335 at $34.28
    $1.25M
    1.3% of stake
  • Nov 24, 2025No plan
    John Todd Mitchell
    Chief Legal Officer & Sec. · sold 159,556 at $29.89
    $4.77M
    17% of stake
  • Nov 24, 2025
    Evelyn S Dilsaver
    Director · bought 16,724 at $29.90
    $500k
    278% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PACS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Skilled Nursing Care Facilities

Spot a number that looks wrong? Check it in PACS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PACS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.